Codiak BioSciences Inc.

https://www.codiakbio.com

Codiak, founded in 2015, is the leader in the rapidly developing field of exosome therapeutics. The company was formed on the basis of research from the VentureLabs innovation unit of Flagship Pioneering; the research of Jan Lotvall, M.D., Ph.D., Chairman of the Krefting Research Centre at University of Gothenburg, Sweden; and Raghu Kalluri, M.D., Ph.D., at The University of Texas MD Anderson Cancer Center in Houston, Texas. *

	Start	2015-01-01 established
	Industry	exosome therapeutic
	Industry 2	BIOTECH
	Person	Williams, Douglas E. (Doug) (Codiak BioSciences 201711 CEO before Biogen 201101–201507 EVP RnD before ZymoGenetics CEO

	Region	Cambridge, MA
	Country	United States (USA)
	Street	500 Technology Square 9th Floor
	City	02139 Cambridge, MA
	Tel	+1-617-949-4100
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«: Codiak BioSciences, Inc.. (11/29/17). "Press Release: Codiak BioSciences Closes $76.5 Million Series C Financing". Cambridge, MA.

		Record changed: 2024-05-04

Picture Berlin Partner Top News Healthtech Company Mika 650x200px

More documents for Codiak BioSciences Inc.

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]